727
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Chromium in Stainless Steel Welding Fume Suppresses Lung Defense Responses Against Bacterial Infection in Rats

&
Pages 117-127 | Received 15 Dec 2006, Accepted 24 Jan 2007, Published online: 09 Oct 2008

Figures & data

TABLE 1 Concentrations of welding fume sample (mg/instillate)

FIG. 1 Pulmonary clearance of bacteria by rats pre-exposed to (A) 2 mg of manual metal arc, stainless steel (MMA-SS) welding fume or (B) 0.82 mg insoluble Fe2O3, 0.60 mg soluble Cr2Na2O7, or 0.06 mg insoluble NiO alone or in combination. The MMA-SS and metal samples were intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means in Log10 base units ± standard error of measurement (n = 4–12); *significantly greater than corresponding saline control at each timepoint (p < 0.05).

FIG. 1 Pulmonary clearance of bacteria by rats pre-exposed to (A) 2 mg of manual metal arc, stainless steel (MMA-SS) welding fume or (B) 0.82 mg insoluble Fe2O3, 0.60 mg soluble Cr2Na2O7, or 0.06 mg insoluble NiO alone or in combination. The MMA-SS and metal samples were intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means in Log10 base units ± standard error of measurement (n = 4–12); *significantly greater than corresponding saline control at each timepoint (p < 0.05).

FIG. 2 Percent change in body weight of rats pre-exposed to (A) 2 mg of manual metal arc, stainless steel (MMA-SS) welding fume or (B) 0.82 mg insoluble Fe2O3, 0.60 mg soluble Cr2Na2O7, or 0.06 mg insoluble NiO alone or in combination. The MMA-SS and metal samples were intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–12); *significantly reduced than corresponding saline control at each time point (p < 0.05).

FIG. 2 Percent change in body weight of rats pre-exposed to (A) 2 mg of manual metal arc, stainless steel (MMA-SS) welding fume or (B) 0.82 mg insoluble Fe2O3, 0.60 mg soluble Cr2Na2O7, or 0.06 mg insoluble NiO alone or in combination. The MMA-SS and metal samples were intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–12); *significantly reduced than corresponding saline control at each time point (p < 0.05).

TABLE 2 Lung inflammation and injury

FIG. 3 Zymosan-stimulated chemiluminescence of macrophages recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled three days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly greater than corresponding saline control at Day 6 (p < 0.05).

FIG. 3 Zymosan-stimulated chemiluminescence of macrophages recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled three days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly greater than corresponding saline control at Day 6 (p < 0.05).

FIG. 4 TNFα measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly less than corresponding saline control at Days 3 and 6 (p < 0.05).

FIG. 4 TNFα measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly less than corresponding saline control at Days 3 and 6 (p < 0.05).

FIG. 5 IL-6 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly greater than corresponding saline control at Days 3 and 6 (p < 0.05); n.d. = not detected.

FIG. 5 IL-6 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly greater than corresponding saline control at Days 3 and 6 (p < 0.05); n.d. = not detected.

FIG. 6 IL-10 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7).

FIG. 6 IL-10 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7).

FIG. 7 IL-2 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled three days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly less than corresponding saline control at Days 3 and 6 (p < 0.05).

FIG. 7 IL-2 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled three days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly less than corresponding saline control at Days 3 and 6 (p < 0.05).

FIG. 8 IL-12p70 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly greater than corresponding saline control at Day 6 (p < 0.05).

FIG. 8 IL-12p70 measured within the bronchoalveolar lavage fluid (BALF) recovered from rats pre-exposed to 0.60 mg soluble Cr2Na2O7. The Cr sample was intratracheally instilled 3 days prior to intratracheal inoculation with 5 × 103 L. monocytogenes. Control animals were pretreated with saline. Values are means ± standard error of measurement (n = 4–7); *significantly greater than corresponding saline control at Day 6 (p < 0.05).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.